PRICE T ROWE ASSOCIATES INC /MD/ - THERAVANCE INC ownership

THERAVANCE INC's ticker is THRX and the CUSIP is 88338T104. A total of 152 filers reported holding THERAVANCE INC in Q2 2013. The put-call ratio across all filers is 0.53 and the average weighting 0.4%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of THERAVANCE INC
ValueSharesWeighting
Q4 2015$4,423,000
+42.9%
419,604
-2.7%
0.00%0.0%
Q3 2015$3,096,000
-51.7%
431,194
+21.6%
0.00%0.0%
Q2 2015$6,408,000
+20.7%
354,594
+5.0%
0.00%0.0%
Q1 2015$5,308,000
+9.4%
337,664
-1.5%
0.00%0.0%
Q4 2014$4,852,000
-22.0%
342,864
-5.9%
0.00%0.0%
Q3 2014$6,224,000
-42.5%
364,194
+0.2%
0.00%
-50.0%
Q2 2014$10,820,000
-1.3%
363,346
+2.5%
0.00%0.0%
Q1 2014$10,964,000
-65.5%
354,359
-60.2%
0.00%
-50.0%
Q4 2013$31,736,000
-61.5%
890,220
-55.9%
0.00%
-81.0%
Q3 2013$82,500,000
-83.6%
2,017,620
-84.6%
0.02%
-68.7%
Q2 2013$503,248,00013,061,2000.07%
Other shareholders
THERAVANCE INC shareholders Q2 2013
NameSharesValueWeighting ↓
Baupost Group 19,815,983$338,655,0005.90%
Litespeed Management, L.L.C. 2,670,695$45,642,0001.76%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 2,790,913$47,697,0001.76%
Proxima Capital Management, LLC 915,000$15,637,0001.69%
IRIDIAN ASSET MANAGEMENT LLC/CT 8,196,372$140,076,0001.44%
PERRY CAPITAL 1,831,099$31,293,0001.14%
Roundview Capital LLC 140,145$2,395,0001.08%
SECTORAL ASSET MANAGEMENT INC 971,438$16,602,0000.70%
Realm Partners LLC 139,982$2,392,0000.68%
BB BIOTECH AG 743,244$12,702,0000.52%
View complete list of THERAVANCE INC shareholders